 | • レポートコード：MRC2-11QY02564 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗炎症薬のグローバル市場について調査・分析したレポートです。種類別（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他）市場規模、用途別（皮膚発疹、慢性関節炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗炎症薬の競争状況、市場シェア ・世界の抗炎症薬市場：種類別市場規模 2015年-2020年（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他） ・世界の抗炎症薬市場：種類別市場規模予測 2021年-2026年（アスピリン、イブプロフェン、ナプロキセン、セレコキシブ、その他） ・世界の抗炎症薬市場：用途別市場規模 2015年-2020年（皮膚発疹、慢性関節炎、その他） ・世界の抗炎症薬市場：用途別市場規模予測 2021年-2026年（皮膚発疹、慢性関節炎、その他） ・北米の抗炎症薬市場分析：米国、カナダ ・ヨーロッパの抗炎症薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗炎症薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗炎症薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗炎症薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Abbott Laboratories、Johnson & Johnson、Merck & Co.、Pfizer、Amgen、Sanofi、Novartis、Eli Lilly、Amgen、Bayer、Novacap、Kopran Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Anti-inflammatory Drugs Market
The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anti-inflammatory Drugs Scope and Market Size
Anti-inflammatory Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-inflammatory Drugs market is segmented into
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
Segment by Application, the Anti-inflammatory Drugs market is segmented into
Skin Rashes
Chronic Arthritis
Other
Regional and Country-level Analysis
The Anti-inflammatory Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-inflammatory Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-inflammatory Drugs Market Share Analysis
Anti-inflammatory Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-inflammatory Drugs business, the date to enter into the Anti-inflammatory Drugs market, Anti-inflammatory Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
Bayer
Novacap
Kopran Ltd.
1 Study Coverage
1.1 Anti-inflammatory Drugs Product Introduction
1.2 Market Segments
1.3 Key Anti-inflammatory Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Type
1.4.2 Aspirin
1.4.3 Ibuprofen
1.4.4 Naproxen
1.4.5 Celecoxib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Anti-inflammatory Drugs Market Size Growth Rate by Application
1.5.2 Skin Rashes
1.5.3 Chronic Arthritis
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anti-inflammatory Drugs Market Size, Estimates and Forecasts
2.1.1 Global Anti-inflammatory Drugs Revenue 2015-2026
2.1.2 Global Anti-inflammatory Drugs Sales 2015-2026
2.2 Global Anti-inflammatory Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anti-inflammatory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anti-inflammatory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-inflammatory Drugs Competitor Landscape by Players
3.1 Anti-inflammatory Drugs Sales by Manufacturers
3.1.1 Anti-inflammatory Drugs Sales by Manufacturers (2015-2020)
3.1.2 Anti-inflammatory Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Anti-inflammatory Drugs Revenue by Manufacturers
3.2.1 Anti-inflammatory Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Anti-inflammatory Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anti-inflammatory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anti-inflammatory Drugs Revenue in 2019
3.2.5 Global Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anti-inflammatory Drugs Price by Manufacturers
3.4 Anti-inflammatory Drugs Manufacturing Base Distribution, Product Types
3.4.1 Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anti-inflammatory Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anti-inflammatory Drugs Market Size by Type (2015-2020)
4.1.1 Global Anti-inflammatory Drugs Sales by Type (2015-2020)
4.1.2 Global Anti-inflammatory Drugs Revenue by Type (2015-2020)
4.1.3 Anti-inflammatory Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anti-inflammatory Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Anti-inflammatory Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Anti-inflammatory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anti-inflammatory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anti-inflammatory Drugs Market Size by Application (2015-2020)
5.1.1 Global Anti-inflammatory Drugs Sales by Application (2015-2020)
5.1.2 Global Anti-inflammatory Drugs Revenue by Application (2015-2020)
5.1.3 Anti-inflammatory Drugs Price by Application (2015-2020)
5.2 Anti-inflammatory Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Anti-inflammatory Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-inflammatory Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-inflammatory Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anti-inflammatory Drugs by Country
6.1.1 North America Anti-inflammatory Drugs Sales by Country
6.1.2 North America Anti-inflammatory Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anti-inflammatory Drugs Market Facts & Figures by Type
6.3 North America Anti-inflammatory Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Anti-inflammatory Drugs by Country
7.1.1 Europe Anti-inflammatory Drugs Sales by Country
7.1.2 Europe Anti-inflammatory Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anti-inflammatory Drugs Market Facts & Figures by Type
7.3 Europe Anti-inflammatory Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anti-inflammatory Drugs by Region
8.1.1 Asia Pacific Anti-inflammatory Drugs Sales by Region
8.1.2 Asia Pacific Anti-inflammatory Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Type
8.3 Asia Pacific Anti-inflammatory Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anti-inflammatory Drugs by Country
9.1.1 Latin America Anti-inflammatory Drugs Sales by Country
9.1.2 Latin America Anti-inflammatory Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anti-inflammatory Drugs Market Facts & Figures by Type
9.3 Central & South America Anti-inflammatory Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anti-inflammatory Drugs by Country
10.1.1 Middle East and Africa Anti-inflammatory Drugs Sales by Country
10.1.2 Middle East and Africa Anti-inflammatory Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Anti-inflammatory Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Anti-inflammatory Drugs Products Offered
11.1.5 Roche Related Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Description and Business Overview
11.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories Anti-inflammatory Drugs Products Offered
11.2.5 Abbott Laboratories Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Anti-inflammatory Drugs Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Description and Business Overview
11.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck & Co. Anti-inflammatory Drugs Products Offered
11.4.5 Merck & Co. Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Anti-inflammatory Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Description and Business Overview
11.6.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Amgen Anti-inflammatory Drugs Products Offered
11.6.5 Amgen Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Anti-inflammatory Drugs Products Offered
11.7.5 Sanofi Related Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Description and Business Overview
11.8.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Novartis Anti-inflammatory Drugs Products Offered
11.8.5 Novartis Related Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Description and Business Overview
11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly Anti-inflammatory Drugs Products Offered
11.9.5 Eli Lilly Related Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Description and Business Overview
11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Amgen Anti-inflammatory Drugs Products Offered
11.10.5 Amgen Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Anti-inflammatory Drugs Products Offered
11.1.5 Roche Related Developments
11.12 Novacap
11.12.1 Novacap Corporation Information
11.12.2 Novacap Description and Business Overview
11.12.3 Novacap Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Novacap Products Offered
11.12.5 Novacap Related Developments
11.13 Kopran Ltd.
11.13.1 Kopran Ltd. Corporation Information
11.13.2 Kopran Ltd. Description and Business Overview
11.13.3 Kopran Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Kopran Ltd. Products Offered
11.13.5 Kopran Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anti-inflammatory Drugs Market Estimates and Projections by Region
12.1.1 Global Anti-inflammatory Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Anti-inflammatory Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Anti-inflammatory Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Anti-inflammatory Drugs Sales Forecast (2021-2026)
12.2.2 North America: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Anti-inflammatory Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Anti-inflammatory Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anti-inflammatory Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anti-inflammatory Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anti-inflammatory Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Anti-inflammatory Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Anti-inflammatory Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anti-inflammatory Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anti-inflammatory Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anti-inflammatory Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anti-inflammatory Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anti-inflammatory Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anti-inflammatory Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anti-inflammatory Drugs Market Segments
Table 2. Ranking of Global Top Anti-inflammatory Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anti-inflammatory Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Aspirin
Table 5. Major Manufacturers of Ibuprofen
Table 6. Major Manufacturers of Naproxen
Table 7. Major Manufacturers of Celecoxib
Table 8. Major Manufacturers of Others
Table 9. Global Anti-inflammatory Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Anti-inflammatory Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Anti-inflammatory Drugs Sales by Regions 2015-2020 (K Units)
Table 12. Global Anti-inflammatory Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Anti-inflammatory Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Anti-inflammatory Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global Anti-inflammatory Drugs Sales Share by Manufacturers (2015-2020)
Table 16. Global Anti-inflammatory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Anti-inflammatory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Drugs as of 2019)
Table 18. Anti-inflammatory Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Anti-inflammatory Drugs Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Anti-inflammatory Drugs Price (2015-2020) (USD/Unit)
Table 21. Anti-inflammatory Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anti-inflammatory Drugs Product Type
Table 23. Date of International Manufacturers Enter into Anti-inflammatory Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 26. Global Anti-inflammatory Drugs Sales Share by Type (2015-2020)
Table 27. Global Anti-inflammatory Drugs Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Anti-inflammatory Drugs Revenue Share by Type (2015-2020)
Table 29. Anti-inflammatory Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 31. Global Anti-inflammatory Drugs Sales Share by Application (2015-2020)
Table 32. North America Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units)
Table 33. North America Anti-inflammatory Drugs Sales Market Share by Country (2015-2020)
Table 34. North America Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 36. North America Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 37. North America Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
Table 38. North America Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 39. North America Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
Table 40. Europe Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units)
Table 41. Europe Anti-inflammatory Drugs Sales Market Share by Country (2015-2020)
Table 42. Europe Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 44. Europe Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 45. Europe Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
Table 46. Europe Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 47. Europe Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Anti-inflammatory Drugs Sales by Region (2015-2020) (K Units)
Table 49. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Anti-inflammatory Drugs Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 53. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 55. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
Table 56. Latin America Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units)
Table 57. Latin America Anti-inflammatory Drugs Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 60. Latin America Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 61. Latin America Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
Table 62. Latin America Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 63. Latin America Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Anti-inflammatory Drugs Sales by Country (2015-2020) (K Units)
Table 65. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Anti-inflammatory Drugs Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Anti-inflammatory Drugs Sales by Type (2015-2020) (K Units)
Table 69. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Anti-inflammatory Drugs Sales by Application (2015-2020) (K Units)
Table 71. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
Table 72. Roche Corporation Information
Table 73. Roche Description and Major Businesses
Table 74. Roche Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 75. Roche Product
Table 76. Roche Recent Development
Table 77. Abbott Laboratories Corporation Information
Table 78. Abbott Laboratories Description and Major Businesses
Table 79. Abbott Laboratories Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Abbott Laboratories Product
Table 81. Abbott Laboratories Recent Development
Table 82. Johnson & Johnson Corporation Information
Table 83. Johnson & Johnson Description and Major Businesses
Table 84. Johnson & Johnson Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Johnson & Johnson Product
Table 86. Johnson & Johnson Recent Development
Table 87. Merck & Co. Corporation Information
Table 88. Merck & Co. Description and Major Businesses
Table 89. Merck & Co. Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Merck & Co. Product
Table 91. Merck & Co. Recent Development
Table 92. Pfizer Corporation Information
Table 93. Pfizer Description and Major Businesses
Table 94. Pfizer Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Pfizer Product
Table 96. Pfizer Recent Development
Table 97. Amgen Corporation Information
Table 98. Amgen Description and Major Businesses
Table 99. Amgen Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Amgen Product
Table 101. Amgen Recent Development
Table 102. Sanofi Corporation Information
Table 103. Sanofi Description and Major Businesses
Table 104. Sanofi Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Sanofi Product
Table 106. Sanofi Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Eli Lilly Corporation Information
Table 113. Eli Lilly Description and Major Businesses
Table 114. Eli Lilly Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Eli Lilly Product
Table 116. Eli Lilly Recent Development
Table 117. Amgen Corporation Information
Table 118. Amgen Description and Major Businesses
Table 119. Amgen Anti-inflammatory Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Amgen Product
Table 121. Amgen Recent Development
Table 122. Bayer Corporation Information
Table 123. Bayer Description and Major Businesses
Table 124. Bayer Anti-inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. Bayer Product
Table 126. Bayer Recent Development
Table 127. Novacap Corporation Information
Table 128. Novacap Description and Major Businesses
Table 129. Novacap Anti-inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Novacap Product
Table 131. Novacap Recent Development
Table 132. Kopran Ltd. Corporation Information
Table 133. Kopran Ltd. Description and Major Businesses
Table 134. Kopran Ltd. Anti-inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Kopran Ltd. Product
Table 136. Kopran Ltd. Recent Development
Table 137. Global Anti-inflammatory Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 138. Global Anti-inflammatory Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 139. Global Anti-inflammatory Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 140. Global Anti-inflammatory Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 141. North America: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 142. North America: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Europe: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 144. Europe: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Asia Pacific: Anti-inflammatory Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 146. Asia Pacific: Anti-inflammatory Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 147. Latin America: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 148. Latin America: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Middle East and Africa: Anti-inflammatory Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 150. Middle East and Africa: Anti-inflammatory Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 152. Key Challenges
Table 153. Market Risks
Table 154. Main Points Interviewed from Key Anti-inflammatory Drugs Players
Table 155. Anti-inflammatory Drugs Customers List
Table 156. Anti-inflammatory Drugs Distributors List
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-inflammatory Drugs Product Picture
Figure 2. Global Anti-inflammatory Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Aspirin Product Picture
Figure 4. Ibuprofen Product Picture
Figure 5. Naproxen Product Picture
Figure 6. Celecoxib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-inflammatory Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Skin Rashes
Figure 10. Chronic Arthritis
Figure 11. Other
Figure 12. Anti-inflammatory Drugs Report Years Considered
Figure 13. Global Anti-inflammatory Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Anti-inflammatory Drugs Sales 2015-2026 (K Units)
Figure 15. Global Anti-inflammatory Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Anti-inflammatory Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Anti-inflammatory Drugs Sales Market Share by Region in 2019
Figure 18. Global Anti-inflammatory Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Anti-inflammatory Drugs Revenue Market Share by Region in 2019
Figure 20. Global Anti-inflammatory Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Drugs Revenue in 2019
Figure 22. Anti-inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Anti-inflammatory Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Anti-inflammatory Drugs Sales Market Share by Type in 2019
Figure 25. Global Anti-inflammatory Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Anti-inflammatory Drugs Revenue Market Share by Type in 2019
Figure 27. Global Anti-inflammatory Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Anti-inflammatory Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Anti-inflammatory Drugs Sales Market Share by Application in 2019
Figure 30. Global Anti-inflammatory Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Anti-inflammatory Drugs Revenue Market Share by Application in 2019
Figure 32. North America Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Anti-inflammatory Drugs Sales Market Share by Country in 2019
Figure 35. North America Anti-inflammatory Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Anti-inflammatory Drugs Market Share by Type in 2019
Figure 41. North America Anti-inflammatory Drugs Market Share by Application in 2019
Figure 42. Europe Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Anti-inflammatory Drugs Sales Market Share by Country in 2019
Figure 45. Europe Anti-inflammatory Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Anti-inflammatory Drugs Market Share by Type in 2019
Figure 57. Europe Anti-inflammatory Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Anti-inflammatory Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Anti-inflammatory Drugs Revenue Market Share by Region in 2019
Figure 62. China Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Anti-inflammatory Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Anti-inflammatory Drugs Market Share by Application in 2019
Figure 86. Latin America Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Anti-inflammatory Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Anti-inflammatory Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Anti-inflammatory Drugs Market Share by Type in 2019
Figure 97. Latin America Anti-inflammatory Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Anti-inflammatory Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Anti-inflammatory Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Anti-inflammatory Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Anti-inflammatory Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Anti-inflammatory Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Anti-inflammatory Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Anti-inflammatory Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Anti-inflammatory Drugs Market Share by Application in 2019
Figure 110. North America Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Anti-inflammatory Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Anti-inflammatory Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- 抗炎症ペプチドの世界市場（～2026年） Anti-inflammatory peptides also known as antiflammins inhibit inflammation of a mammal's skin, lacerations of the musculature, mucous membranes, or injury into the air spaces of the lungs. Anti-inflammatory peptides act by hindering synthesis of platelet-activating factor, neutrophil aggregation and…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗腫瘍薬の世界市場（～2026年） Tumor is also termed as neoplasm and it is caused by an abnormal proliferation of tissues. This abnormal proliferation can be due to genetic mutations. Tumors can be subcategorized as benign and malignant. Benign is not destructive however, possess a potential to turn into a malignant tumor... It ha…
- 止瀉薬の世界市場（～2026年） Market Analysis and Insights: Global Anti Diarrheal Drugs Market The global Anti Diarrheal Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti Diarrheal Drugs Scope and Market Size Anti Diarrheal Drugs market is…